KLHL12 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.362000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.467600E-01
Normal-vs-Stage2
6.169000E-01
Normal-vs-Stage3
8.816200E-02
Normal-vs-Stage4
6.974800E-01
Stage1-vs-Stage2
5.771600E-01
Stage1-vs-Stage3
9.974500E-02
Stage1-vs-Stage4
6.237600E-01
Stage2-vs-Stage3
4.056000E-02
Stage2-vs-Stage4
2.212000E-01
Stage3-vs-Stage4
3.978400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.868600E-01
Normal-vs-AfricanAmerican
8.939200E-01
Normal-vs-Asian
9.450200E-01
Caucasian-vs-AfricanAmerican
3.455000E-01
Caucasian-vs-Asian
4.307200E-01
AfricanAmerican-vs-Asian
8.305200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.666000E-01
Normal-vs-Female
6.123400E-01
Male-vs-Female
4.976600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.647600E-01
Normal-vs-Age(41-60Yrs)
5.450600E-01
Normal-vs-Age(61-80Yrs)
6.469400E-01
Normal-vs-Age(81-100Yrs)
9.575200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.000020E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.499200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.473000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.017600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.321800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.229400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.832400E-01
Normal-vs-Daily Drinker
3.270200E-01
Normal-vs-Weekly Drinker
7.624800E-01
Normal-vs-Occasional Drinker
7.473000E-01
Normal-vs-Social Drinker
8.707400E-01
Non Drinker-vs-Daily Drinker
7.180800E-01
Non Drinker-vs-Weekly Drinker
4.835400E-01
Non Drinker-vs-Occasional Drinker
1.692000E-02
Non Drinker-vs-Social Drinker
1.753010E-01
Daily Drinker-vs-Weekly Drinker
3.759600E-01
Daily Drinker-vs-Occasional Drinker
1.304210E-02
Daily Drinker-vs-Social Drinker
1.219020E-01
Weekly Drinker-vs-Occasional Drinker
2.743800E-01
Weekly Drinker-vs-Social Drinker
7.123000E-01
Occasional Drinker-vs-Social Drinker
3.770800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.240000E-02
Normal-vs-Grade 2
1.917520E-02
Normal-vs-Grade 3
1.040210E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.077000E-01
Grade 1-vs-Grade 3
1.926440E-01
Grade 1-vs-Grade 4
4.240000E-02
Grade 2-vs-Grade 3
5.334100E-02
Grade 2-vs-Grade 4
1.917520E-02
Grade 3-vs-Grade 4
1.040210E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.022200E-01
Normal-vs-NonDiabetic
6.520400E-01
Diabetic-vs-NonDiabetic
1.127760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.420200E-01
Normal-vs-NoPancreatitis
5.999200E-01
Pancreatitis-vs-NoPancreatitis
9.045800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.664600E-01
Normal-vs-N1
5.837800E-01
N0-vs-N1
1.703410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.196400E-01
Normal-vs-TP53-NonMutant
9.998400E-01
TP53-Mutant-vs-TP53-NonMutant
2.224800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
